News of the WeekClinical Trials

Company, Researchers Battle Over Data Access

See allHide authors and affiliations

Science  10 Nov 2000:
Vol. 290, Issue 5494, pp. 1063
DOI: 10.1126/science.290.5494.1063

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A dispute between university-based researchers and the corporation that funded their study is threatening to erupt into a $7 million to $10 million legal battle. Last week, the researchers reported that a large clinical trial of an immune system booster to treat HIV-infected people found that the drug isn't effective in slowing progression to AIDS or reducing mortality. The company that developed the drug tried to block publication of the study unless the researchers included the company's analysis of a subset of the data that suggests the drug might help some people. The researchers refused.